Transforming growth factors-beta (TGFs-/?) are representative of a superfamily whose members were first identified as regulators of morphogenesis and differentiation, and subsequently found to be structurally related. Other members of the family include the activins and inhibins, BMPs, MIS, the DPP-C gene product and Vg- 
Introduction
Transforming growth factors-beta (TGFs-¡3) are a family of polypeptide hormones which probably act over relatively confined physiological spaces in vivo. This is a somewhat complicated task for a number of reasons. As indicated above, TGF-/2 is a family of five closely related factors (TGF-/S1 to TGF-/35) within a superfamily of several other factors implicated in essential elements of development. These other factors include the decapentaplegic gene product of Drosophila, the Vg-1 gene product and mesoderm inducing factor in Xenopus, Mullerian Inhibiting Substance, the Bone Morphogenic Proteins, and the activins and inhibins (Massague, 1990 ). This suggests that there may be a family of related receptors with differential affinities for different members of the superfamily. Another complicating element is that the known effects of TGF-/? are varied and in some instances diametrically opposed in different cell systems. It is intriguing that TGF-/3 has a potent growth inhibitory effect on some epithelial cell lines, but it is also mitogenic in some culture systems, such as osteoblasts . And finally, experimentally, we have found that there is a relatively low level of specific cell-surface TGF-/3 binding and that this activity is distributed among three distinct cell surface binding proteins.
Distribution of specific TGF-^-binding proteins
In the course of investigating the activities of TGF-/3 over the last six years, our laboratory has characterized the TGF-/5 binding patterns of over one hundred different cell lines, primary cells and tissues (Fig. 1A) (Massague, 1990) . It is striking that the general pattern is so similar in most cells analyzed. Briefly, the experimental approach is to bind iodinated TGF-/3 to cells, crosslink the ligand to cell surface proteins to which it is associated with a bifunctional crosslinking reagent such as disuccinimidyl suberate, solubilize the cell membranes with detergent and separate the labeled proteins on SDS-polyacrylamide gels with subsequent autoradiography. This method commonly identifies three proteins (Fig. IB) called signalling, or S, mutants. When complementation analysis was performed, none of the mutant hybrids were complementary, suggesting that all the R and S mutants isolated are mutants in the same gene, presumably the TGF-/? receptor gene. It is also apparent from this analysis that all the mutants isolated were recessive mutations. All mutant-parental fusions were fully responsive to TGF-/? with normal receptor profiles. These studies have been extended and selection of M vlLu mutants has been performed with lower doses (25 p M ) of TGF-/J2. In addition to the R and S mutant classes, a third class of mutants defective in the expression of both the Type I and Type II proteins has been isolated (DR mutants) (M. Laiho and others, unpublished observations). Complementation analysis of these mutants is not complete, so the genetic basis of these mutations is still unknown. Several explanations for this phenotype are possible. DR mutants may be the result of mutations of two distinct loci encoding for the Type I and Type II proteins, although the frequency of isolation of these mutants argues strongly against this. Another possibility is that the two genes are linked and a single large deletion can knock out expression of both genes. A third possibility is that the two proteins are associated intracellularly and some mutations in one or the other of the proteins prevent the expression of both. These possibilities are the subject of active investigation in the laboratory. We are also attempting to complement these mutants by cDNA and genomic transfection to clone the genes responsible for these mutations.
Somatic cell mutants defective in TGF-/J responsiveness

More direct evidence supporting specific roles of these proteins in TGF-
Betaglycan
While mutant analysis has revealed the functional significance of the Type I and Type II proteins, the fact remains that in the majority of cells we have screened, the major component of cell surface TGF-/3 binding activity is associated with a large proteoglycan species with apparent molecular weight of 2 00-400x l 0 3Mr. This molecule is a complex mixed chondroitin/heparan sulfate proteoglycan 
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